(Q36085841)

12 August 2017

1 reference

title

Mechanisms of action of mycophenolate mofetil (English)

1 reference

12 August 2017

A C Allison

1

1 reference

12 August 2017

1 January 2005

1 reference

12 August 2017

1 reference

12 August 2017

14 Suppl 1

1 reference

12 August 2017

s2-8

1 reference

Immunosuppressive drugs: the first 50 years and a glance forward

12 August 2017

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2109OA

The effect of aminomethylpteroylglutamic acid on the development of skin hypersensitivity and on antibody formation in guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2109OA

Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5'-nucleotidase-mediated conversion of adenine nucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2109OA

The purine path to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2109OA

Prolonged survival of human-kidney homografts by immunosuppressive drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2109OA

Two lessons from the interface of genetics and medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2109OA

Immunological observations on patients with Lesch-Nyhan syndrome, and on the role of de-novo purine synthesis in lymphocyte transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2109OA

Mycophenolate mofetil and its mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2109OA

Interleukin-15: a new cytokine target for the treatment of inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2109OA

IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2109OA

Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2109OA

Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2109OA

Mechanisms of action of mycophenolate mofetil in preventing chronic rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2109OA

A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2109OA

B cells as therapeutic targets for rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2109OA

Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2109OA

Sweet 'n' sour: the impact of differential glycosylation on T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2109OA

Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2109OA

Renal fibrosis: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2109OA

Fibrogenesis in chronic allograft rejection: underlying mechanisms and pharmacological control

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2109OA

Mycophenolic acid antagonizes the activation of cultured human mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2109OA

Mycophenolate mofetil (MMF, RS-61443) inhibits inflammation and smooth muscle cell proliferation in rat aortic allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2109OA

Treatment by mycophenolate mofetil of advanced graft vascular disease in non-human primate recipients of orthotopic aortic allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2109OA

Systemic lupus erythematosus and accelerated atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2109OA

Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2109OA

Bone histomorphometry in glucocorticoid-induced osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2109OA

Azathioprine metabolism: pharmacokinetics of 6-mercaptopurine, 6-thiouric acid and 6-thioguanine nucleotides in renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2109OA

Organospecific activation of azathioprine in mice: role of liver metabolism in mutation induction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2109OA

Mycophenolates in transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2109OA

Mycophenolate mofetil versus azathioprine therapy is associated with a significant protection against long-term renal allograft function deterioration

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2109OA

10.1191/0961203305LU2109OA

21 January 2018

Identifiers

DOI

1 reference

release_d6hcvpf325dvhorpbx2r673imq

12 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/d6hcvpf325dvhorpbx2r673imq

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

15803924

1 reference

PubMed ID

15803924